Innovative vaccine approaches-a Keystone Symposia report
The rapid development of COVID-19 vaccines was the result of decades of research to establish flexible vaccine platforms and understand pathogens with pandemic potential, as well as several novel changes to the vaccine discovery and development processes that partnered industry and governments. And...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Wiley
2022
|
| _version_ | 1826309220312547328 |
|---|---|
| author | Cable, J Rappuoli, R Klemm, EJ Kang, G Mutreja, A Wright, GJ Pizza, M Castro, SA Hoffmann, JP Alter, G Carfi, A Pollard, AJ Krammer, F Gupta, RK Wagner, CE Machado, V Modjarrad, K Corey, L B Gilbert, P Dougan, G Lurie, N Bjorkman, PJ Chiu, C Nemes, E Gordon, SB Steer, AC Rudel, T Blish, CA Sandberg, JT Brennan, K Klugman, KP Stuart, LM Madhi, SA Karp, CL |
| author_facet | Cable, J Rappuoli, R Klemm, EJ Kang, G Mutreja, A Wright, GJ Pizza, M Castro, SA Hoffmann, JP Alter, G Carfi, A Pollard, AJ Krammer, F Gupta, RK Wagner, CE Machado, V Modjarrad, K Corey, L B Gilbert, P Dougan, G Lurie, N Bjorkman, PJ Chiu, C Nemes, E Gordon, SB Steer, AC Rudel, T Blish, CA Sandberg, JT Brennan, K Klugman, KP Stuart, LM Madhi, SA Karp, CL |
| author_sort | Cable, J |
| collection | OXFORD |
| description | The rapid development of COVID-19 vaccines was the result of decades of research to establish flexible vaccine platforms and understand pathogens with pandemic potential, as well as several novel changes to the vaccine discovery and development processes that partnered industry and governments. And while vaccines offer the potential to drastically improve global health, low-and-middle-income countries around the world often experience reduced access to vaccines and reduced vaccine efficacy. Addressing these issues will require novel vaccine approaches and platforms, deeper insight how vaccines mediate protection, and innovative trial designs and models. On June 28-30, 2021, experts in vaccine research, development, manufacturing, and deployment met virtually for the Keystone eSymposium "Innovative Vaccine Approaches" to discuss advances in vaccine research and development. |
| first_indexed | 2024-03-07T07:30:53Z |
| format | Journal article |
| id | oxford-uuid:bd668e02-6c32-48b0-aeae-eece582b1c7b |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T07:30:53Z |
| publishDate | 2022 |
| publisher | Wiley |
| record_format | dspace |
| spelling | oxford-uuid:bd668e02-6c32-48b0-aeae-eece582b1c7b2023-01-16T09:23:02ZInnovative vaccine approaches-a Keystone Symposia reportJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:bd668e02-6c32-48b0-aeae-eece582b1c7bEnglishSymplectic ElementsWiley2022Cable, JRappuoli, RKlemm, EJKang, GMutreja, AWright, GJPizza, MCastro, SAHoffmann, JPAlter, GCarfi, APollard, AJKrammer, FGupta, RKWagner, CEMachado, VModjarrad, KCorey, LB Gilbert, PDougan, GLurie, NBjorkman, PJChiu, CNemes, EGordon, SBSteer, ACRudel, TBlish, CASandberg, JTBrennan, KKlugman, KPStuart, LMMadhi, SAKarp, CLThe rapid development of COVID-19 vaccines was the result of decades of research to establish flexible vaccine platforms and understand pathogens with pandemic potential, as well as several novel changes to the vaccine discovery and development processes that partnered industry and governments. And while vaccines offer the potential to drastically improve global health, low-and-middle-income countries around the world often experience reduced access to vaccines and reduced vaccine efficacy. Addressing these issues will require novel vaccine approaches and platforms, deeper insight how vaccines mediate protection, and innovative trial designs and models. On June 28-30, 2021, experts in vaccine research, development, manufacturing, and deployment met virtually for the Keystone eSymposium "Innovative Vaccine Approaches" to discuss advances in vaccine research and development. |
| spellingShingle | Cable, J Rappuoli, R Klemm, EJ Kang, G Mutreja, A Wright, GJ Pizza, M Castro, SA Hoffmann, JP Alter, G Carfi, A Pollard, AJ Krammer, F Gupta, RK Wagner, CE Machado, V Modjarrad, K Corey, L B Gilbert, P Dougan, G Lurie, N Bjorkman, PJ Chiu, C Nemes, E Gordon, SB Steer, AC Rudel, T Blish, CA Sandberg, JT Brennan, K Klugman, KP Stuart, LM Madhi, SA Karp, CL Innovative vaccine approaches-a Keystone Symposia report |
| title | Innovative vaccine approaches-a Keystone Symposia report |
| title_full | Innovative vaccine approaches-a Keystone Symposia report |
| title_fullStr | Innovative vaccine approaches-a Keystone Symposia report |
| title_full_unstemmed | Innovative vaccine approaches-a Keystone Symposia report |
| title_short | Innovative vaccine approaches-a Keystone Symposia report |
| title_sort | innovative vaccine approaches a keystone symposia report |
| work_keys_str_mv | AT cablej innovativevaccineapproachesakeystonesymposiareport AT rappuolir innovativevaccineapproachesakeystonesymposiareport AT klemmej innovativevaccineapproachesakeystonesymposiareport AT kangg innovativevaccineapproachesakeystonesymposiareport AT mutrejaa innovativevaccineapproachesakeystonesymposiareport AT wrightgj innovativevaccineapproachesakeystonesymposiareport AT pizzam innovativevaccineapproachesakeystonesymposiareport AT castrosa innovativevaccineapproachesakeystonesymposiareport AT hoffmannjp innovativevaccineapproachesakeystonesymposiareport AT alterg innovativevaccineapproachesakeystonesymposiareport AT carfia innovativevaccineapproachesakeystonesymposiareport AT pollardaj innovativevaccineapproachesakeystonesymposiareport AT krammerf innovativevaccineapproachesakeystonesymposiareport AT guptark innovativevaccineapproachesakeystonesymposiareport AT wagnerce innovativevaccineapproachesakeystonesymposiareport AT machadov innovativevaccineapproachesakeystonesymposiareport AT modjarradk innovativevaccineapproachesakeystonesymposiareport AT coreyl innovativevaccineapproachesakeystonesymposiareport AT bgilbertp innovativevaccineapproachesakeystonesymposiareport AT dougang innovativevaccineapproachesakeystonesymposiareport AT lurien innovativevaccineapproachesakeystonesymposiareport AT bjorkmanpj innovativevaccineapproachesakeystonesymposiareport AT chiuc innovativevaccineapproachesakeystonesymposiareport AT nemese innovativevaccineapproachesakeystonesymposiareport AT gordonsb innovativevaccineapproachesakeystonesymposiareport AT steerac innovativevaccineapproachesakeystonesymposiareport AT rudelt innovativevaccineapproachesakeystonesymposiareport AT blishca innovativevaccineapproachesakeystonesymposiareport AT sandbergjt innovativevaccineapproachesakeystonesymposiareport AT brennank innovativevaccineapproachesakeystonesymposiareport AT klugmankp innovativevaccineapproachesakeystonesymposiareport AT stuartlm innovativevaccineapproachesakeystonesymposiareport AT madhisa innovativevaccineapproachesakeystonesymposiareport AT karpcl innovativevaccineapproachesakeystonesymposiareport |